Common Contracts
6 similar Securities Purchase Agreement contracts by CervoMed Inc., Denali Therapeutics Inc., Mineralys Therapeutics, Inc., others
CERVOMED INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2024 • CervoMed Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of March 28, 2024 (the “Effective Date”), by and between CERVOMED INC., a Delaware corporation (the “Company”), and each of the purchasers whose names are set forth on Schedule A hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
CERVOMED INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 28th, 2024 • CervoMed Inc. • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of March 28, 2024 (the “Effective Date”), by and between CERVOMED INC., a Delaware corporation (the “Company”), and each of the purchasers whose names are set forth on Schedule A hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
NEKTAR THERAPEUTICS SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 4th, 2024 • Nektar Therapeutics • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of March 4, 2024 (the “Effective Date”), by and between NEKTAR THERAPEUTICS, a Delaware corporation (the “Company”), and TCG Crossover Fund II, L.P., a Delaware limited partnership (the “Purchaser”).
DENALI THERAPEUTICS INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 27th, 2024 • Denali Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (the “Agreement”) is made as of February 27, 2024 (the “Effective Date”), by and among Denali Therapeutics Inc., a Delaware corporation (the “Company”), and each of the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
MINERALYS THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 8th, 2024 • Mineralys Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (the “Agreement”) is made as of February 7, 2024 (the “Effective Date”), by and between Mineralys Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the purchasers whose names and addresses are set forth on Schedule A hereto (each, a “Purchaser” and, collectively, the “Purchasers”).
TANGO THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 10th, 2023 • Tango Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (the “Agreement”) is made as of August 10, 2023 (the “Effective Date”), by and among Tango Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers whose names and addresses are set forth on the signature pages hereof (each, a “Purchaser” and, collectively, the “Purchasers”).
